Abstract
Tuberculosis represents the main cause of mortality due to a single pathogen infection. Advances in anti-tuberculosis therapies are urgently required both for treatment of the 8-12 million new cases of tuberculosis leading to 2 million deaths each year, as well as for the 2 billion individuals already infected with M. tuberculosis, who are at the risk of developing disease. The present review summarizes the actually available information about currently existing therapies and perspectives for future innovative therapeutic approaches.
Keywords: tuberculosis, mycobacteria, therapeutics, immune-modulators
Letters in Drug Design & Discovery
Title: Tuberculosis Therapeutics: Past Achievements, Present Road-Blocks and Future Perspectives
Volume: 1 Issue: 4
Author(s): Sanjay K. Garg, Marilina B. Santucci, Fouad Seghrouchni, Cesare Saltini, Prakash S. Bisen, Vittorio Colizzi and Maurizio Fraziano
Affiliation:
Keywords: tuberculosis, mycobacteria, therapeutics, immune-modulators
Abstract: Tuberculosis represents the main cause of mortality due to a single pathogen infection. Advances in anti-tuberculosis therapies are urgently required both for treatment of the 8-12 million new cases of tuberculosis leading to 2 million deaths each year, as well as for the 2 billion individuals already infected with M. tuberculosis, who are at the risk of developing disease. The present review summarizes the actually available information about currently existing therapies and perspectives for future innovative therapeutic approaches.
Export Options
About this article
Cite this article as:
Garg K. Sanjay, Santucci B. Marilina, Seghrouchni Fouad, Saltini Cesare, Bisen S. Prakash, Colizzi Vittorio and Fraziano Maurizio, Tuberculosis Therapeutics: Past Achievements, Present Road-Blocks and Future Perspectives, Letters in Drug Design & Discovery 2004; 1 (4) . https://dx.doi.org/10.2174/1570180043398515
DOI https://dx.doi.org/10.2174/1570180043398515 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Molecular Modeling Used to Evaluate CYP2C9-Dependent Metabolism: Homology Modeling, Molecular Dynamics and Docking Simulations
Current Drug Metabolism Molecular Properties Prediction and Synthesis of Novel Pyrazoline Carboxamide Analogs as Antitubercular Agents
Anti-Infective Agents Recent Updates in Imperative Natural Compounds for Healthy Brain and Nerve Function: A Systematic Review of Implications for Multiple Sclerosis
Current Drug Targets Immunotherapeutic Impact of Toll-like Receptor Agonists in Breast Cancer
Anti-Cancer Agents in Medicinal Chemistry Radziszewski Reaction: An Elegant, Easy, Simple and Efficient Method to Synthesise Imidazoles
Current Organic Synthesis Bacterial Efflux Pumps Involved in Multidrug Resistance and their Inhibitors: Rejuvinating the Antimicrobial Chemotherapy
Recent Patents on Anti-Infective Drug Discovery A Comprehensive Review on DNA Gyrase Inhibitors
Infectious Disorders - Drug Targets Fluoroquinolones: Blessings Or Curses
Current Drug Targets Peptide Deformylase: A New Target in Antibacterial, Antimalarial and Anticancer Drug Discovery
Current Medicinal Chemistry Anti-Arthritic Effects of Immunomodulatory Peptide Injected in Joints
Current Drug Delivery New Agents Promote Neuroprotection in Parkinson’s Disease Models
CNS & Neurological Disorders - Drug Targets Chemokines and Chemokine Receptors Blockers as New Drugs for the Treatment of Chronic Obstructive Pulmonary Disease
Current Medicinal Chemistry Structure-Based Approaches to the Development of Novel Anti-Malarials
Current Drug Targets Editorial [Tuberculosis Drugs and Drug Targets]
Infectious Disorders - Drug Targets The Metabolic Syndrome and HIV Infection
Current Pharmaceutical Design Leishmaniasis: Prevention, Parasite Detection and Treatment
Current Medicinal Chemistry Tryptophan Catabolites and Their Impact on Multiple Sclerosis Progression
Current Pharmaceutical Design Anti-Mycobacterium tuberculosis Activity of Calophyllum brasiliense Extracts Obtained by Supercritical Fluid Extraction and Conventional Techniques
Current Pharmaceutical Biotechnology 4-Aminoquinoline Based Molecular Hybrids as Antimalarials: An Overview
Current Topics in Medicinal Chemistry Natural and Synthetic Compounds with an Antimycobacterial Activity
Mini-Reviews in Organic Chemistry